Drug Profile
Enoxaparin sodium biosimilar - Pharmathen
Alternative Names: ThorinaneLatest Information Update: 21 Dec 2018
Price :
$50
*
At a glance
- Originator Pharmathen
- Class Anti-ischaemics; Antithrombotics; Ischaemic heart disorder therapies; Low molecular weight heparins
- Mechanism of Action Factor Xa inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Deep vein thrombosis; Myocardial infarction; Unstable angina pectoris; Venous thromboembolism
Most Recent Events
- 21 Jul 2016 Preregistration for Deep vein thrombosis in European Union (SC) before July 2016
- 21 Jul 2016 Preregistration for Myocardial infarction (acute ST segment elevation myocardial infarction) in European Union (SC, 60 mg/0.6 mL, 80 mg/0.8 mL, and 100 mg/1 mL) before July 2016
- 21 Jul 2016 Preregistration for Venous thromboembolism (Prevention) in European Union (SC, 40 mg/0.4 mL) before July 2016